Stability of Ang2 plasma level during the course of CLL. The comparison between 2 sequential plasma samples derived from 35 CLL patients shows no statistical difference in Ang2 level both for the 6 treated cases (left) and for the 29 untreated patients (right; P = .917 and P = .347, respectively, Wilcoxon test).